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ABSTRACT 
CONTEXT:  Retropubic (RT-TVT) and transobturator miurethral (TO-TVT) mid-urethral sling 
(MUS) are popular surgical treatments for female stress urinary incontinence (SUI). The long-term 
efficacy and safety of the procedures is still a topic of intense clinical research and several 
randomized controlled trials (RCTs) have been published in the last years 
OBJECTIVE: To evaluate the efficacy and safety of MUS compared with other surgical 
treatments for female SUI. 
EVIDENCE ACQUISITION: A systematic review and meta-analysis of the literature was 
performed using the Medline, Scopus,  and Web of Science databases to update our previously 
published analyses. 
EVIDENCE SYNTHESIS: Twenty-eight RCTs were identified. In total, the meta-analyses 
included 15,855 patients. Patients receiving MUS  had significantly higher overall (odds ratio [OR]: 
0.59;p=0.0003) and objective (OR: 0.51;  p=0.001) cure rates than those receiving Burch 
colposuspension (BC).  Patients undergoing MUS and pubovaginal slings had similar cure rates. 
Patients treated with RT-TVT had higher subjective (OR: 0.83; p=0.03) and objective (OR: 0.82; 
p=0.01) cure rates than those receiving TO-TVT. However, the latter had  lower risk of 
intraoperative bladder or vaginal perforation (OR 2.4;p=0.0002), pelvic hematoma (OR 
2.61;p=0.002), urinary tract infections (OR 1.31;p=0.04) and voiding lower urinary tract symptoms 
(LUTS) (OR 1.66;p=0.002). Sensitivity analyses limited to RCTs with follow-up durations >60 mo 
demonstrated similar outcomes for RP-TVT and TO-TVT. No significant differences in efficacy 
were identified comparing inside-to-out and outside-to-in TO-TVT but vaginal perforations were 
less common with the former (OR 0.21;p=0.0002).  
CONCLUSIONS: The present analysis confirms the superiority of MUS over BC. The studies 
comparing insertion of RT-TVT and TO-TVT showed higher subjective and objective cure rates for 
the RP-TVT but at the cost of higher risks of some complications and voiding LUTS. Efficacy of 
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inside-out and outside-in techniques of TO-TVT insertion was similar, although the risk of vaginal 
perforation was lower in the inside-to-out TO-TVT. 
PATIENT SUMMARY: 
Retropubic and transobturator midurethral slings are a popular treatment for female stress urinary 
incontinence. The available literature suggest that those slings are either more effective or safer than 
other older surgical procedures. Retropubic tapes are followed with slightly higher continence rates 
as compared with the transobturator tapes but are associated with higher risk of intra- and 
postoperative complications.  
 
KEY WORDS: stress urinary incontinence, Burch colposuspension, pubovaginal sling, stress 
urinary incontinence, retropubic vaginal tape, tension free tape, transobturator tape 
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TAKE-HOME MESSAGES 
The present analysis confirms the superiority of MUS over Burch colposuspension. The studies 
comparing insertion of RT-TVT and TO-TVT showed higher subjective and objective cure rates for 
the RP-TVT but at the cost of higher risks of some complications and voiding LUTS. Efficacy of 
inside-out and outside-in techniques of TO-TVT insertion was similar, although the risk of vaginal 
perforation was lower in the inside-to-out TO-TVT 
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INTRODUCTION 
Surgical treatment is often the preferred option for women with stress urinary incontinence (SUI) 
who have failed conservative management strategies [1].  
Several different surgical procedures have been reported, with synthetic midurethral slings (MUS) 
being the most commonly adopted surgical procedures. Several systematic reviews and meta-
analyses of randomized controlled trials comparing the different surgical approaches have been 
reported [2-6]. In our previous systematic review, we have shown that women treated with 
retropubic tension-free vaginal tapes (RP-TVT) had slightly higher objective continence rates than 
those treated with Burch colposuspension (BC) but they faced a higher risk of intraoperative 
complications. RP-TVT and pubovaginal slings (PVS) were similarly effective, although patients 
with PVS were more likely to experience postoperative storage lower urinary tract symptoms 
(LUTS). RP-TVT were associated with objective cure rates slightly higher than transobturator 
tension-free vaginal tapes (TO-TVT) but subjective cure rates were similar. TO-TVT, however, had 
a lower risk of bladder/vaginal perforations and postoperative storage LUTS [4].  
Furthermore, concerns have been raised on the use of synthetic mesh for surgical treatment  of 
female SUI and prolapse surgery. That was primarily due to the risk of complications   including 
mesh exposure/erosion, dyspareunia, infections, and pain. The FDA issued a series of statements 
concluding that serious complications associated with transvaginal mesh for pelvic organ prolapse 
(POP) repair and are not un-common nevertheless they emphasized that this does not apply to use 
of mesh for SUI or abdominal surgery. However, very recently, a Scottish population-based study, 
demonstrated that mesh surgical procedures for SUI were associated with lower risk of early 
postoperative complications and subsequent prolapse surgery, as well as similar risks of further 
incontinence surgery and later complications, as compared with open colposuspension [7].  I n late 
2015, various working groups worldwide reported on the use of transvaginal mesh in 
Scotland, England, and Europe (SCENIHR) in  surgical  t reatment  of  SUI and POP [8-
10].  All have emphasized the need of further research  in  the  field.  Therefore, we elected to 
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update our previous meta-analyses of the literature in the field of primary surgical treatment of 
female SUI. 
 
MATERIALS AND METHODS 
The updated systematic review of the literature was performed in July 2014 and last updated on 1st 
November 2016 using the Medline, Scopus, and Web of Science databases. The Medline search 
used a complex search strategy including both medical subject heading (MeSH) and free text 
protocols, as was done in the previous reviews [2-4].  Specifically, the MeSH search was conducted 
by combining the following terms retrieved from the MeSH browser provided by Medline: Urinary 
Incontinence, Stress, and Suburethral Slings. Multiple “free text” searches were also performed, 
searching for the following terms individually in the fields title and abstract of the records: 
Urinar*incont*, TVT, tension-free vaginal tape*, Tension-free vaginal sling*, Transobturator tape*, 
Trans-obturator sling*, TVT-obturator, TVT-O, TOT, suprapubic arc sling*, SPARC sling*, 
intravaginal slingplasty, IVS sling, Uratape, ObTAPE, Prepubic sling*, Prepubic TVT, Prepubic 
tape*, PelviLace, Ureter, Aris, In-Fast, Monarc, I-Stop, and BioArc. Subsequently, the search 
results were pooled, and the following limits used: humans, Entrez Date from 2009/08/01. No 
limitations regarding language of publication or type of publication were used. The searches on 
Scopus, and Web of Science used only the free-text protocol, with the same key words. 
Subsequently, the query results were pooled and the same temporal limit applied. Moreover, 
Cochrane Database of Systematic Review was searched using the key word “urinary incontinence”. 
Hand-search of congress abstracts was not performed. 
A total of 958 records were retrieved from Medline, 1789 from Scopus, and 1477 from Web of 
Science. Four of the authors reviewed the full texts to select the papers relevant to the review topic. 
Specifically, all the RCTs, discussing outcomes (ie, continence rates, satisfaction rates, 
complication rates) from the use of MUS as predominantly primary surgical treatment of SUI were 
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selected. RCTs reporting on the use of MUS exclusively in patients who had previously failed other 
surgical treatments were excluded. The selected papers were categorized according to the grade of 
evidence: an adequately sampled single RCT was considered to have level 1b evidence; a low-
quality RCT to have level 2b evidence [11]. The quality of the retrieved RCTs was assessed using 
the Jadad score [12].  
To evaluate the efficacy of the different procedures, both objective criteria (stress test, pad test, 
urodynamics) and subjective criteria (patients’ perception of the clinical improvement, expressed by 
validated questionnaires, institutional questionnaires, or open interview) were considered. In the 
case of papers reporting patient outcomes through the use of mixed subjective and objective end 
points (eg, no referred leakage and negative stress test, no referred leakage and negative pad test), 
an overall continence rate was shown. Whenever multiple reports at different follow-up duration 
were available for a RCT, the figures from the reports with longest follow-up were considered.  
Meta-analysis was conducted using Review Manager software v. 4.2 (Cochrane Collaboration, 
Oxford, UK). Specifically, statistical heterogeneity was tested using the chi-squared test. A value of 
p < 0.10 was used to indicate heterogeneity. In the case of a lack of heterogeneity, fixed-effects 
models were used for the meta-analyses. The results were expressed as weighted means difference 
(WMD) and standard deviations for continuous outcomes and as an odds ratio (OR) with a 95% 
confidence interval (CI) for dichotomous variables. In the comparisons of RP-TVT and TO-TVT, 
the large number of publications with appropriate data allowed us to perform subgroup analyses 
according to the device used. In this case, we differentiated retropubic TVTTM vs inside-to-out  
trasobturator (TVT-OTM), retropubic TVTTM vs outside-to-in TO tapes (including different kits) and 
other retropubic vs other transobutaror tapes (reporting studies where either retropubic tapes 
different from TVTTM were used or studies where both inside-to-out  and outside-to-in TO tapes 
were used without differentiating the results). No covariate adjustments were performed, as usually 
done in the Cochrane collaboration systematic reviews of RCTs. 
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For all the comparisons, sensitivity analyses limited to RCTs of good methodological quality (i.e., 
those with a Jadad score ≥3) and to RCTs with follow-up duration ≥ 60 months were performed. 
The presence of publication bias was evaluated through a funnel plot, as previously reported [13]. 
The study complied with the recently reported Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) statement [14]. 
 
RESULTS 
Figure 1 summarizes the literature review process which lead to the identification of the 30 papers 
reporting data from 28 different RCTs used to update the meta-analysis (Figure 1). 
Specifically, two papers compared MUS and BC [15, 16]; three papers compared MUS and PVS 
[17-19];  20 papers compared RP-TVT and TO-TVT [20-39]; two papers compared RP-TVT and 2 
different types of TO-TVT  [40; 41]; 3 studies compared different TO-TVT [42-44].  
Seventeen reports were from 15 high-quality RCTs [16, 19, 21-25, 27-29, 32-34, 38, 41-43]. 
Only 7 RCTs reported outcomes of surgery at a follow-up interval  ≥ 60 mo [16, 19, 21, 34, 37-39]. 
In total, the metaanalyses included 15,855 patients.  
 
Randomized controlled trials comparing midurethral tapes to Burch colposuspension 
Supplemental Table 1 in the appendix summarizes the results of the only 2 new RCTs reporting 
continence, and complication rates following MUS or BC as primary treatment for stress 
urinary incontinence. Of note, all BCs in these 2 new RCTs had been performed 
laparoscopically. 
Fig. 2 shows the forest plots concerning the meta-analyses of continence rates following MUS or 
BC. 
MUS were associated with significantly higher cure rates compared to BC, considering success 
rates evaluated according to any definition of continence (81.82% vs 73.64%, respectively; OR: 
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0.59; 95% CI: 0.45–0.79; p = 0.0003; Fig. 2a), and objective continence rates (negative stress test:  
79.7% vs 67.8%, respectively; OR: 0.51; 95% CI: 0.34–0.76; p = 0.001; Fig. 2b). Notably, 
stratifying the BC outcomes according to the surgical approach (open vs laparoscopic), the 
significant difference in favor of MUS pertained for “any definition of continence” and 
“objective continence rates”. Similarly, there was some evidence of an effect in favor of MUS 
as compared to laparoscopic BC for “any definition of continence” but it did not meet 
conventional levels of statistical significance (OR,0.49 95%CI 0.23, 1.04, p=0.06 – Figure 2-A). 
Subgroup analyses limited to the 3 studies with follow-up duration ≥60 months demonstrated better 
objective cure rate for MUS (OR: 0.54; 95% CI: 0.36–0.82; p = 0.004) but only a non-statistically 
significant trend for overall continence rate (OR: 0.39; 95% CI: 0.15–1.03; p = 0.06) and subjective 
continence rate (OR: 0.69; 95% CI: 0.45–1.06; p = 0.09) 
 
Randomized controlled trials comparing midurethral tapes to pubovaginal slings 
Supplemental Table 2 in the appendix summarized the results of the new RCTs reporting 
continence, and complication rates following MUS or PVS as primary treatment for stress urinary 
incontinence. 
Fig. 3 shows the forest plots concerning the metaanalyses of cure, and complication rates. 
On the whole, MUS and PVS were associated with similar effectiveness and similar prevalence of 
complications. However, there was there was some evidence of an effect in favor of MUS for re-
operation rates but it did not meet conventional levels of statistical significance (3.9% vs 7.7%, 
respectively; OR 0.5; p=0.06 – Figure 3-G). 
Only one single RCT had a follow-up duration ≥ 60 mo [19]. 
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Randomized controlled trials comparing retropubic with transobturator tape 
Supplemental Table 3 and 4 in the appendix summarize continence, complication, and reoperation 
rates of the RCTs comparing RP-TVT and TO-TVT as “primary” treatment for SUI. 
Fig. 4 shows the forest plots concerning the metaanalyses of continence, complication, and 
reoperation rates. 
Objective (86% vs 84%, respectively; OR: 0.82; 95% CI: 0.70–0.96; p = 0.01; Fig. 4b) and 
subjective (78% vs 74%, respectively; OR: 0.83; 95% CI: 0.70–0.98; p = 0.03; Fig. 4c) continence 
rates were superior in RP-TVT, whereas overall continence rate was similar with RP-TVT and TO-
TVT. Considering “any definition of cure” there was no statistical significance between RP-TVT 
and TO-TVT groups (OR 1.16, 95%CI: 0.89-1.51, p=0.27 – Figure 4-A). 
With regards to complications, risk of intraoperative bladder or vaginal perforation (4.8% vs 1.6%, 
respectively; OR 2.4; 95% CI 1.51 – 3.90; p = 0.0002; Fig. 4-D), pelvic hematoma (1.7% vs 0.3%, 
respectively; OR 2.61; 95% CI 1.41 – 4.82; p = 0.002; Fig. 4-E), urinary tract infections (10% vs 
7.9%, respectively; OR 1.31; 95% CI 1.02 – 2.68; p = 0.04; Fig. 4-G) and voiding LUTS (9.2% vs 
5.7%, respectively; OR 1.66; 95% CI 1.2 – 2.3; p = 0.002; Fig. 4-I) were significantly higher in RP-
TVT. Conversely, the risk of vaginal erosion was lower in RP tapes (1.8% vs 2.8%, respectively; 
OR 0.64; 95% CI 0.44 – 0.92; p = 0.002; Fig. 4-F), which was mainly due to the higher risk of 
vaginal erosions in outside-to-in TO-TVT. Finally, rates of storage LUTS, clean intermittent self-
catheterization (CISC)/recatheterization, and re-operation were similar in RP-TVT and TO-TVT 
tapes.  
Table 1 summarizes sensitivity analyses performed on high quality RCTs. Such analyses 
reconfirmed advantages for RP-TVT in terms of objective cure rates (OR 0.76; p = 0.006) and risk 
of vaginal erosions (OR 0.56; p = 0.03), whereas bladder/vaginal perforations were less prevalent 
with TO tapes (OR 1.41; p = 0.002). 
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Further sensitivity analyses limited to the 5 RCTs with follow-up durations >60 mo [21, 34, 37-39] 
demonstrated similar outcomes for RP-TVT and TO-TVT in terms of objective cure rate, subjective 
cure rate, vaginal erosions, storage and voiding LUTS, and reoperation rates (see supplemental 
figure 1). 
Randomized controlled trials comparing different transobturator midurethral tapes 
Supplemental Tables 5 and 6 in the appendix summarize continence, complication, and reoperation 
rates of the RCTs comparing different TO-TVT tapes as the treatment for primary SUI. 
Fig. 5 shows the forest plots concerning the metaanalyses of continence, complication, and 
reoperation rates. 
No significant differences in efficacy were identified comparing inside-to-out and outside-to-in TO-
TVT.  Regarding complications, vaginal perforations were less common with the inside-to-out TO-
TVT (2.6% vs 11.8%, respectively; OR 0.21; p = 0.0002). Moreover, there was also a non-
statistically significant trend for vaginal erosions in favor of inside-to-out TO-TVT (OR 0.37; p = 
0.06). All the other complications were similarly prevalent inside-to-out and outside-to-in TO-TVT. 
No RCT has follow-up duration ≥ 60 mo.  
 
Publication bias 
Funnel plots of all the studies used in this meta-analysis were generated for all the evaluated 
comparisons. Only few studies lay outside the 95% CI with an even distribution about the vertical, 
suggesting little evidence of publication bias (data not extensively shown).  
DISCUSSION 
Surgical treatment is the standard approach for women with SUI who have failed conservative 
management [45]. More than 200 surgical procedures have been described over time. However, BC, 
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PVS and MUS are the most popular and effective surgical treatments for woman with SUI [46]. To 
date, MUS represent the most frequently used surgical intervention in Europe for women with SUI 
[45]. Current EAU guidelines recommend MUS in women with uncomplicated SUI as the preferred 
surgical intervention and BC (either open or laparoscopic) or autologous PVS in women with SUI if 
MUS cannot be considered [45]. In 2010, in a previous systematic review and meta-analyses of 
RCTs evaluating the efficacy, complication, and reoperation rates of MUS compared with other 
surgical treatments for female SUI, Novara et al previously showed a statistically significant higher 
overall and objective cure rates in favor of MUS compared to BC, although at the cost of a 
statistically significant higher risk of bladder and vaginal perforations. The comparison between 
MUS and PVS showed similar overall and subjective cure rates although the safety profile was 
different. MUS were associated with higher risk of bladder perforation while the incidence of 
storage LUTS and the reoperation rate were higher among patients undergoing PVS [4]. The 
comparison between retropubic and trans-obturator routes for MUS placement showed a slightly 
higher objective cure rate in favor of the former although subjective cure rates were similar. Again, 
the safety profile was different: TO-TVT were associated with a lower risk of bladder and vaginal 
perforations, hematoma, and storage LUTS. Conversely, the incidence of vaginal erosion was 
higher among patients receiving TO-TVT and was mainly due to the higher risk of vaginal erosions 
in outside-to-in TO-TVT. The reoperation rate, the incidence of urinary tract infections, and the 
need for clean intermittent catheterization or re-catheterization was similar between the two 
techniques. Finally, based only on the evidences from three available RCTs, the meta-analysis 
demonstrated similar outcomes for the inside-out and outside-in procedures in terms of objective 
and subjective cure rates and safety profile [4].  
Despite being based on many trials of good methodological quality, that meta-analysis had some 
limitations such as heterogeneity of outcomes measures and the lack of RCTs with long term 
follow-up as only two studies reported data at follow-up ≥ 60 months. Due to the fact that several 
RCTs have been published in the field since the publication of that report, we elected to update our 
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previous meta-analysis. The updated comparison among MUS and BC reconfirmed the superiority 
of MUS in terms of overall and objective continence rates as well as the equivalence in terms of 
subjective continence rates. Those results were mainly determined by the differences observed 
between MUS and open BC. Similarly, there was a trend towards more favorable outcomes with 
MUS compared to laparoscopic BC in all sub-analyses. Sensitivity analyses limited to the RCTs 
with follow-up duration ≥60 mo reconfirmed the advantages in terms of objective continence rates, 
whereas only non-statistically significant trend in favor of MUS was found for overall and 
subjective continence rates.    
With regards of the comparison among MUS and PVS, the present analysis reconfirmed the 
absence of significant differences between both groups in terms of overall and subjective 
continence rates, as well as prevalence of pelvic hematoma, vaginal erosions, voiding LUTS. 
Conversely, the incidence of storage LUTS was significantly lower in patients treated with MUS. 
Notably, while the previous meta-analysis showed higher re-operation rate in patients receiving 
PVS, the present report showed a similar trend but did not reach statistical significance.  
On comparing RP-TVT and TO-TVT, we found overall higher objective and subjective continence 
rates in patients treated with RP-TVT. However, although statistically significant, such difference in 
success rates were minimal (just 2% and 4% difference in objective and subjective cure rates, 
respectively) and probably of marginal clinical relevance if we consider the difference in 
complication rates. Interestingly, the study by Costantini et al. found that the long-term continence 
rate after MUS placement tended to decrease in patients who underwent TO-TVT, whereas 
remained stable for those who underwent RP-TVT [37]. Yet, our estimations including only RCTs 
with at least 5-year follow-up did not show any difference in objective or subjective cure rates 
between the retropubic and transobturator approaches.  Except for vaginal erosions, our results 
showed the transobturator approach to be associated with lower risk of most intraoperative and 
postoperative complications, which is the main reasons why TO-TVT is now preferred by most 
surgeons for the primary surgical treatment of female over RP-TVT. Reassuringly, the above results 
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pertained on sensitivity analyses limited to the RCTs of highest methodological quality. In the end, 
retropubic approach might offer a slight advantage over the transobturator approach in terms of 
objective success rates but at the costs of higher complication rate.  
With regard to the comparison between inside-out and outside-in TO-TVT, we found no 
statistically significant differences between the two surgical approaches in terms of continence 
rates, whereas the risk of vaginal perforation was lower in inside-to-out TO-TVT. Moreover, there 
was also a clear trend in favor of inside-to-out TO-TVT for vaginal erosions, although it did not 
reach statistical significance.  
There has been a growing interest in the likehood of chronic pain and dyspareunia following 
MUS. In our review, only a limited number of RCTs reported on long-term pain following 
surgery for SUI. Kenton et al reported a few cases of long-term pain at 5-yr follow-up following 
RP-TVT or TO-TVT [47]. Interestingly, Khan et al. reported presence of scar pain also 
following autologous PVS, indicating that such risk is not limited to MUS [19]. Two recent 
studies  reported 6.4% and 9% groin/inguinal pain/discomfort at 7 and 10-years follow-up 
respectively following TO-TVT [39,49]. Intractable suprapubic pain has been previously 
described following colposuspension and defined as post-colposuspension syndrome. Even less 
data are available on long-term prevalence of dyspareunia in patients receiving MUS for SUI. 
The available RCTs have reported just a few cases of de novo dyspareunia [32, 44]. However, 
the available literature seems to suggest improvements in sexual function for the sexually active  
patients treated with MUS for SUI [50-51]. 
The present study has several strengths. First, represents the most up-to-date and most 
comprehensive summary of the currently available evidence in surgical treatments of female 
SUI, including the most commonly adopted surgical treatments, with the only exception of the 
single-incision mini-sling. That choice was in line with the inclusion and exclusion criteria set at 
the moment of the original systematic reviews and meta-analyses [2-4]. Moreover, a recent 
systematic review and meta-analysis published by Mostafa el at. [48], demonstrating similar 
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outcome for mini-slings and traditional MUS. However, most of the available RCTs reported 
only short- or intermediate-term follow-up data.  Secondly, the paper complies with the currently 
available standard to report systematic review and meta-analysis [14]. Finally, the review 
included a relatively high number of RCTs with long-term follow-up (≥60 months) which 
bridges a significant gap in the current literature. Taken together, those data corroborate the 
findings of the previous reports of ours with stronger results based on large number of patients 
included in analyses and, above all, larger number of studies with follow-up duration ≥60 
months. 
However, we acknowledge a number of limitations. First, a small percentage of the patients 
included in some RCTs had already received previous surgical treatments for SUI. However, such 
percentage was extremely low. Similar to our previous reports, the evaluation of subjective and 
objective outcomes was heterogeneous and not all studies utilized validated questionnaires. 
Although the number of studies with follow-up ≥ 60 months was higher with respect to previous 
meta-analysis, the short duration of the follow-up remains a limit of available literature as most 
studies report short- or intermediate-term follow-up. Limited data were available of potentially 
interesting outcomes such as long-term pain and dyspareunia. Moreover, the accuracy of 
complication reporting is limited in most RCTs, not complying with the standardized Martin criteria 
[52]. Finally, studies comparing MUS to other surgical treatments, such as bulking agent injections 
are lacking.   
 
CONCLUSIONS 
Overall, the literature summarized in this updated meta-analysis confirms the superiority of MUS 
over Burch colposuspension and PVS for the treatment of primary female SUI. MUS are 
significantly more effective than BC in terms of overall and objective continence rates.  Although 
equivalent to PVS  in terms of overall and subjective continence rates, MUS show a statistically 
significant lower incidence of storage LUTS. The studies comparing insertion of the MUS by the 
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retropubic and transobturator routes showed a slightly higher rate of objective cure rate in favor of 
the RP-TVT but at the cost of higher risks of intra-operative complications and voiding LUTS. No 
significant differences emerged from comparison of inside-out and outside-in techniques of TO-
TVT insertion with regard to efficacy, although the risk of vaginal perforation and, in a lower 
extent, of vaginal erosions were more favorable in the inside-to-out TO-TVT. The heterogeneity in 
outcome measures and the lack of RCTs with long-term follow-up remain major limits of available 
literature.  
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Figure 1: Fig. 1 – Flow diagram of the systematic review and meta-analysis. 
 
 
  
 
 
 
RCT = randomized controlled trial 
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Figure 2: Forest plots of comparisons after midurethral tapes and Burch colposuspension:  
Overall cure rate: continence rate according to (a) any definition of continence; (b) objective 
continence rate; (c) subjective continence rate; 
A) any definition of continence 
 
 
B) Objective continence rate 
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C) Subjective continence rate 
 
 
CI = confidence interval; OR = odds ratio; SUI = stress urinary incontinence. 
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Fig. 3 – Forest plots of comparisons after midurethral tapes and pubovaginal sling: (a) 
Continence rate according to any definition of continence; (b) subjective continence rate; (c) 
pelvic hematoma; (d) vaginal erosions: (e) storage lower urinary tract symptoms; (f) voiding 
lower urinary tract symptoms; (g) reoperation rate. 
 
A) Continence rate according to any definition of cure 
 
 
B) Subjective continence rate 
 
 
C) Pelvic hematoma 
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D) Vaginal erosions 
 
 
E) Storage lower urinary tract symptoms (LUTS) 
 
 
F) Voiding lower urinary tract symptoms (LUTS) 
 
G) reopearation rate 
 
CI = confidence interval; OR = odds ratio; SUI = stress urinary incontinence. 
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Fig. 4 – Forest plots of comparisons after retropubic tape and transobturator tape. (a) 
Continence rate according to any definition of cure; (b) objective continence rate; (c) 
subjective continence rate (nonvalidated questionnaire); (d) bladder or vaginal perforation; 
(e) hematoma; (f) vaginal erosion; (g) urinary tract 
infection; (h) storage lower urinary tract symptoms (LUTS); (i) voiding LUTS; (j) need of 
clean intermittent catheterization or recatheterization; (k) reoperation rate. 
 
A) Continence rate according to any definition of cure 
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B) objective continence rate 
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C) subjective continence rate 
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D) Intraoperative bladder or vaginal perforation 
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E) hematoma 
 
 
 
  
 33 
F) vaginal erosion 
 
 
  
 34 
G) urinary tract infection 
 
 
  
 35 
H) storage lower urinary tract symptoms (LUTS) 
 
 
  
 36 
I) voiding LUTS 
 37 
J) need of clean intermittent catheterization or recatheterization 
 
 
 38 
K) reoperation rate 1 
 2 
 3 
 4 
CI = confidence interval; CIC = clean intermittent catheterization; OR = odds ratio; SD = 5 
standard deviation; SUI = stress urinary incontinence; LUTS: lower urinary tract symptoms 6 
 7 
8 
 39 
Fig. 5 – Forest plots of comparisons after different transobturator tapes: (a) objective continence 9 
rate; (b) subjective continence rate; (c) vaginal perforation; (d) vaginal erosion; (e) urinary tract 10 
infection; (f) storage lower urinary tract symptoms; (g) voiding lower urinary tract symptoms; 11 
(h) need of clean intermittent catheterization or recatheterization. 12 
 13 
A) objective continence rate 14 
 15 
 16 
 17 
B) subjective continence rate 18 
 19 
 20 
 21 
C) vaginal perforation 22 
 23 
 24 
 40 
D) vaginal erosion 25 
 26 
E) urinary tract infection 27 
 28 
F) storage lower urinary tract symptoms  29 
 30 
 31 
32 
 41 
G) voiding lower urinary tract symptoms 33 
 34 
H) need of clean intermittent catheterization or recatheterization. 35 
 36 
 37 
CI = confidence interval; CIC = clean intermittent catheterization; OR = odds ratio; SD = 38 
standard deviation; SUI = stress urinary incontinence; LUTS: lower urinary tract symptoms 39 
 40 
 41 
 42 
Table 1:  Comparisons after retropubic and transobturator tapes . Meta-analysis of all the RCTs and sensitivity analyses for high 42 
quality RCTs 43 
 44 
Retropubic vs transobturator 
tapes 
All RCTs High quality RCTs 
Continence rate 
 RCT Participants OR 95%- CI of 
OR 
P value Difference in 
favor of 
RCT Participant
s 
OR 95%- CI 
of OR 
P 
value 
Difference 
in favor of 
Any definition of continence 9 1374 1.16 0.89–1.51 0.27 None 3 355 0.96 0.42–2.17  0.92 None 
Objective continence rate 31 4796 0.82 0.70–0.96 0.02 RP-TVT  16 3079 0.76 0.63–0.92 0.006 RP-TVT 
Subjective continence rate  22 3247 0.83 0.70–0.98 0.03 RP-TVT 14  2361 0.85 0.7–1.03 0.77 None 
Adverse events 
 RCT Participants OR 95%- CI 
of OR 
P value Difference in 
favor of 
RCT Participant
s 
OR 95%- CI 
of OR 
P 
value 
Difference 
in favor of 
Bladder/vaginal perforation 36 6335 2.5 1.87–3.36 <0.0001 TO-TVT 15 2993 2.41 1.56–3.71 0.002 TO-TVT 
Hematoma 23 3619 2.61 1.41–4.82 0.002 TO-TVT 6 999 2.62 0.81–8.46 0.11 None 
Vaginal erosion 28 4367 0.65 0.45–0.95 0.03 RP-TVT 13 1405 0.56 0.32–0.96 0.03 RP-TVT 
Urinary tract infection 16 3149 1.31 1.02–1.68 0.04 TO-TVT 6 1302 1.28 0.93–1.78 0.13 None 
Storage LUTS 31 52341 1.07 0.9–1.28 0.44 None 12 2531 1.07 0.76–1.5 0.70 None 
Voiding LUTS 15 2429 1.66 1.2–2.3 0.002 TO-TVT 8 1038 1.59 0.85–2.97 0.15 None 
CIC/recatheterization 24 4749 1.14 0.87–1.48 0.34 None 13 1510 1.33 0.81– 2.18  0.27 None 
Reoperation rate 18 3126 1.13 0.65–1.95 0.66 None 8 778 1.33 0.46–3.87 0.6 None 
 45 
